We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+22.57%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$416M
AUM Growth
+$20.8M
Cap. Flow
-$17.1M
Cap. Flow %
-4.12%
Top 10 Hldgs %
20.36%
Holding
141
New
25
Increased
51
Reduced
35
Closed
30

Top Buys

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$6.26M
2
XMTR icon
Xometry
XMTR
+$5.87M
3
ELF icon
e.l.f. Beauty
ELF
+$5.16M
4
RELY icon
Remitly
RELY
+$5.16M
5
GTLS
Chart Industries
GTLS
+$5.02M

Sector Composition

Rank Sector Weight
1 Technology 28.63%
2 Industrials 28.29%
3 Healthcare 18.04%
4 Consumer Discretionary 12.92%
5 Consumer Staples 5.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PI icon
76
Impinj
PI
$5.48B
$2.21M 0.53%
15,180
-19,325
-56% -$3.66M
TBBK icon
77
The Bancorp
TBBK
$2.92B
$2.15M 0.52%
40,895
-73,130
-64% -$4M
AVPT icon
78
AvePoint
AVPT
$2.72B
$2.12M 0.51%
128,550
+7,550
+6% +$115K
FLR icon
79
Fluor
FLR
$8.02B
$2.12M 0.51%
42,941
-40,864
-49% -$2.15M
CW icon
80
Curtiss-Wright
CW
$26B
$2.04M 0.49%
5,735
-510
-8% -$184K
QNST icon
81
QuinStreet
QNST
$1.19B
$2.03M 0.49%
+88,055
New +$1.85M
AAON icon
82
Aaon
AAON
$7.81B
$1.98M 0.48%
+16,815
New +$2.06M
NTRA icon
83
Natera
NTRA
$45B
$1.83M 0.44%
11,590
-1,035
-8% -$151K
SG icon
84
Sweetgreen
SG
$652M
$1.83M 0.44%
57,145
-43,060
-43% -$1.6M
VKTX icon
85
Viking Therapeutics
VKTX
$3.92B
$1.77M 0.43%
43,950
-2,915
-6% -$166K
SARO
86
StandardAero Inc
SARO
$9.57B
$1.71M 0.41%
+69,170
New +$2M
WAL icon
87
Western Alliance Bancorporation
WAL
$8.91B
$1.71M 0.41%
20,435
-21,325
-51% -$1.88M
SKWD icon
88
Skyward Specialty Insurance
SKWD
$2.61B
$1.69M 0.41%
33,530
-25,280
-43% -$1.23M
CYBR
89
DELISTED
CyberArk
CYBR
$1.62M 0.39%
4,860
-430
-8% -$131K
GMED icon
90
Globus Medical
GMED
$11.1B
$1.52M 0.36%
18,340
-6,575
-26% -$519K
ANIP icon
91
ANI Pharmaceuticals
ANIP
$1.76B
$1.49M 0.36%
26,910
+11,990
+80% +$688K
VCEL icon
92
Vericel Corp
VCEL
$2.3B
$1.4M 0.34%
25,430
-27,015
-52% -$1.37M
DYN icon
93
Dyne Therapeutics
DYN
$4.75B
$1.36M 0.33%
57,755
+40,445
+234% +$1.2M
BURL icon
94
Burlington
BURL
$23.2B
$1.33M 0.32%
4,675
+685
+17% +$185K
ONON icon
95
On Holding
ONON
$12.6B
$1.29M 0.31%
23,475
-2,095
-8% -$111K
CSTL icon
96
Castle Biosciences
CSTL
$966M
$1.23M 0.3%
46,265
-108,445
-70% -$3.3M
COHR icon
97
Coherent
COHR
$75.8B
$1.16M 0.28%
12,265
-39,180
-76% -$3.92M
VIK icon
98
Viking Holdings
VIK
$47.1B
$1.04M 0.25%
23,670
-23,380
-50% -$992K
FTI icon
99
TechnipFMC
FTI
$27.4B
$1.04M 0.25%
35,775
-3,190
-8% -$90.8K
NAMS icon
100
NewAmsterdam Pharma
NAMS
$3.32B
$995K 0.24%
38,715
-3,450
-8% -$73.3K

Similar funds

Lisanti Capital Growth's Q4 2024 Portfolio in Review

As of Q4 2024, Lisanti Capital Growth held 141 positions worth $416M, up 5.3% from $395M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Lisanti Capital Growth withdrew a net $17.1M in Q4 2024, closing 30 positions and reducing 35 holdings. Its most notable exit was Meritage Homes, an estimated $6.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Lisanti Capital Growth opened a new position in Lumentum worth $6.74M.

  • Lisanti Capital Growth's largest Q4 2024 buy was Lumentum: 80,275 shares worth $6.74M.
  • Lisanti Capital Growth added most to JBT Marel in Q4 2024, an estimated $4.91M increase.
  • Lisanti Capital Growth's biggest Q4 2024 reduction was FTAI Aviation, cutting an estimated $8.51M.
  • Lisanti Capital Growth fully exited Meritage Homes in Q4 2024, selling an estimated $6.97M.
  • Lisanti Capital Growth's ten largest holdings make up 20% of its $416M portfolio in Q4 2024.
  • Lisanti Capital Growth opened 25 new positions and closed 30 in Q4 2024.
  • Lisanti Capital Growth's portfolio value rose 5.3% quarter-over-quarter to $416M.

Based on Lisanti Capital Growth's 13F filing for Q4 2024, filed 7 Feb 2025.